Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT02842138 · UNKNOWN
Trial details
- NCT number
- NCT02842138
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-02-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.